95-10269. Notice of Partially Closed Meeting  

  • [Federal Register Volume 60, Number 80 (Wednesday, April 26, 1995)]
    [Notices]
    [Page 20476]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-10269]
    
    
    
    ========================================================================
    Notices
                                                    Federal Register
    ________________________________________________________________________
    
    This section of the FEDERAL REGISTER contains documents other than rules 
    or proposed rules that are applicable to the public. Notices of hearings 
    and investigations, committee meetings, agency decisions and rulings, 
    delegations of authority, filing of petitions and applications and agency 
    statements of organization and functions are examples of documents 
    appearing in this section.
    
    ========================================================================
    
    
    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / 
    Notices
    [[Page 20476]]
    
    AGENCY FOR INTERNATIONAL DEVELOPMENT
    
    
    Notice of Partially Closed Meeting
    
        Committee: Malaria Vaccine Program Advisory Committee.
        Date and Location: TvT Conference Room, 1601 North Kent Street, 
    Suite 1104, Arlington, VA 22209.
    
    1. April 27, 9 am-1 pm, (open session)
    2. April 27, 1 pm-2:00 pm, (closed session)
    3. April 27, 2 pm-5:00 pm, (open session)
    
        Agenda: The committee will (1) review progress towards malaria 
    vaccine development by USAID-funded and other invited investigators and 
    (2) review procurement actions, both current and planned. Closed 
    Meeting: Portions of the meeting are closed under exemption 9(B) of 5 
    U.S.C. 552(b) to discuss proposals, scopes of work, cost estimates, and 
    other sensitive procurement information. Disclosures of such 
    information would be likely to significantly frustrate implementation 
    of current and futures procurement by USAID.
    
    FOR FURTHER INFORMATION CONTACT: Steve Landry, Ph.D., Malaria Vaccine 
    Development Program, USAID Office of Health and Nutrition, (SA-18 Room 
    1238), Washington, DC 20523-1817, (703) 875-4508. John Tomaro, Chief, 
    Environmental Health Division, Office of Health and Nutrition, Center 
    for Population, Health and Nutrition, Bureau for Global Programs, Field 
    Support and Research.
    
        Dated: April 21, 1995.
    Mike Kitay,
    Office of the General Counsel.
    
    Charge to the Scientific Consultants Group
    
    April 27, 1995.
        The Scientific Consultants Group (SCG) is charged with providing 
    USAID with advice regarding its efforts to develop vaccines against 
    malaria. During this meeting, the SCG is requested to make comments 
    and recommendations in the following areas:
    
    (1) The role of the SCG
    (2) The MVDP progress on:
         MAP Initiative
         MSP-1 Initiatives
         MVDP Primate Program
         Field Studies in Kenya
    (3) The appropriateness of MVDP plans for new activities:
         SERA Initiative
         AMA-1 Initiative
    (4) The MVDP processes for selecting and developing new antigens
    (5) The coordination among USAID/TDR/CEC
    (6) The projected future scope and direction of the MVDP
    
    USAID-Malaria Vaccine Development Program, Meeting of the Scientific 
    Consultants Group
    
    April 27, 1995.
    
    9:00 a.m. to 5 p.m.
    
         Welcome--Representative of the Office of Health and 
    Nutrition.
         Announcements/Introductions--Dr. Steve Landry.
         Review of Agenda--Dr. Steve Landry/Dr. Robin Powell.
         Approval of Winter '94 Minutes--Dr. Robin Powell/SCG 
    Members.
         Review of the Role of the SCG--Dr. Steve Landry/Dr. 
    Robin Powell.
         Discussion and Comment--SCG Members.
         Charge to the SCG--John Tomaro/Dr. Robin Powell.
    
    Coffee Break
    
         MVDP Update.
    
    Current Initiatives-Overview--Dr. Steve Landry
        MAP Initiative--Dr. Carter Diggs
        MSP-1 Initiatives--Dr. Carter Diggs
        MVDP Primate Program--Dr. Steve Landry
        Field Studies in Kenya--Dr. Steve Landry
    Discussion and Comment--SCG Members
    
    New Initiatives
        SERA Initiative--Dr. Carter Diggs
        AMA-1 Initiative--Dr. Carter Diggs
    Discussion and Comment--SCG Members
    
    Lunch
    
         MVDP process for selecting developing new antigens 
    (closed session--Drs. Landry and Diggs.
         Discussion and Comment (closed session)--SCG Members.
         MVDP/TDR/CEC Coordination--Dr. Steve Landry.
         Discussion and Comment--SCG Members.
         Future directions/priorities for the MVDP--Drs. Landry 
    and Diggs/SCG Members.
         Discussion and Comment--SCG Members.
         Deliberations, Conclusions and Recommendations--SCG 
    Members.
         Debriefing--SCG/David Oot.
         Plans for the next meeting.
    
    [FR Doc. 95-10269 Filed 4-25-95; 8:45 am]
    BILLING CODE 6116-01-M
    
    

Document Information

Published:
04/26/1995
Department:
Agency for International Development
Entry Type:
Notice
Document Number:
95-10269
Pages:
20476-20476 (1 pages)
PDF File:
95-10269.pdf